| HepG2 | | 
Caption: Western blot following CRISPR against EIF2B3 in HepG2 whole cell lysate using EIF2B3 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EIF2B3. EIF2B3 protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow. Releated Sample: BGHcLV16-23 Status: Released Lab: Graveley Lab |
|---|
| K562 | 
Caption: IP-WB analysis of K562 whole cell lysate using the EIF2B3 specific antibody, MA1-078. Lanes 1 and 3 are 2.5% of five million whole cell lysate input. Lanes 2 and 4 are 50% of IP enrichment from five million whole cell lysate using normal IgG antibody and the EIF2B3-specific antibody, MA1-078. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used. Method: immunoprecipitation Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against EIF2B3 in K562 whole cell lysate using EIF2B3 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against EIF2B3. EIF2B3 protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow. Releated Sample: BGKcLV15-27 Status: Released Lab: Graveley Lab |
|---|